Radiation-induced apoptosis - The ceramide-SAPK signaling pathway and clinical aspects

Acta Oncologica

Volumn 37, Issue 6, 1998, Pages 575-581

  Verheij, Marcel ^a   Van Blitterswijk, Wim J ^a   Bartelink, Harry ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DAUNORUBICIN; EDELFOSINE; MILTEFOSINE; SPHINGOMYELIN; STRESS ACTIVATED PROTEIN KINASE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CELL STRUCTURE; DRUG MECHANISM; ENZYME ACTIVITY; GENETIC TRANSFECTION; HOMEOSTASIS; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 0031766349     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430287     Document Type: Article

References (74)

1. Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251-306.
2. Stewart BW. Mechanisms of apoptosis: integration of genetic, biochemical, and cellular indicators. J Natl Cancer Inst 1994; 86: 1286-96.
3. Kerr JFR, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
4. Haimovitz-Friedman A, Kan C-C, Ehleiter D, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994; 180: 525-35.
5. Ojeda F, Dichl HA, Folch H. Radiation-induced membrane changes and programmed cell death. Possible interrelationships. Scanning Micr 1994; 8: 645-51.
6. Stephens LC, Schultheiss TE, Ang KK, Peters LJ. Pathogenesis of radiation injury to the salivary glands and potential methods of protection. Cancer Bull 1989; 41: 106-14.
7. Hannun YA. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 1994; 269: 3125-8.
8. Kolesnick R. Sphingomyelin and derivatives as cellular signals. Prog Lipid es 1991; 30: 1-38.
9. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77: 325-8.
10. Mathias S, Kolesnick R. Ceramide: a novel second messenger. Adv Lipid Res 1993; 25: 65-90.
11. Hartfield PJ, Mayne GC, Murray AW. Ceramide induces apoptosis in PC12 cells. FEBS Lett 1997; 401: 148-52.
12. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci USA 1994; 91: 73-7.
13. Karasavvas N, Erukulla RK, Bittman R, Lockshin R, Zakeri Z. Stereospecific induction of apoptosis in U937 cells by N-octanoyl-sphingosine stereoisomers and N-octyl-sphingosine. Fur J Biochem 1996; 236: 727-37.
14. Quintans J, Kilkus J, McShan CL, Gottschalk AR, Dawson G. Ceramide mediates the apoptotic response of WEHI 231 cells to anti-immunoglobulin, corticosteroids and irradiation. Biochem Biophys Res Comm 1994; 202: 710-4.
15. Boucher L-M, Wiegmann K, Fütterer A, et al. CD28 signals through acidic sphingomyelinase. J Exp Med 1995; 181: 2059-68.
16. Cifone MG, De Maria R, Roncaioli P, et al. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J Exp Med 1993; 177: 1547-52.
17. Gulbins E, Bissonnette R, Mahboubi A, et al. FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway. Immunity 1995; 2: 341-51.
18. Santana P, Peña LA, Haimovitz-Friedman A, et al. Acid sphingomyelinase-deficient human lymphoblasts and mice are defective in radiation-induced apoptosis. Cell 1996; 86: 189-99.
19. Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R. Ceramide synthase mediates daunorubicin-induced apoptosis: An alternative mechanism for generating death signals. Cell 1995; 82: 405-14.
20. Merrill AH, Jones DD. An update of the enzymology and regulation of sphingomyelin metabolism. Biochim Biophys Acta 1009; 1044: 1-12.
21. Yao B, Zhang Y, Delikat S, Mathias S, Basu S, Kolesnick R. Phosphorylation of Raf by ceramide-activated protein kinase. Nature 1995; 378: 307-10.
22. Zhang Y, Yao B, Delikat S, et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell 1997; 89: 63-72.
23. Dobrowsky RT, Hannun YA. Ceramide stimulates a cytosolic protein phosphatase. J Biol Chem 1992; 267: 5048-51.
24. Lozano J, Berra E, Municio MM, et al. Protein kinase C-ζ isoform is critical for êB-dependent promoter activation by sphingomyelinase. J Biol Chem 1994; 269: 19200-2.
25. Müller G, Ayoub M, Storz P, Rennecke J, Fabbro D, Pfizenmaier K. PKCζ is a molecular switch in signal transduction of TNF-α bifunctionally regulated by ceramide and arachidonic acid. EMBO J 1995; 14: 1961-9.
26. Gulbins E, Coggeshall KM, Baier B, et al. Direct stimulation of Vav guanine nucleotide exchange activity for ras by phorbol esters and diglycerides. Mol Cell Biol 1994; 14: 4749-58.
27. Verheij M, Bose R, Lin XH, et al. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 1996; 380: 75-9.
28. Chen Y-R, Wang X, Templeton D, Davis RJ, Tan T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J Biol Chem 1996; 271: 31929-36.
29. Ham J, Babij C, Whitfield J, et al. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995; 14: 927-39.
30. Ichijo H, Nishida E, Irie K, et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90-4.
31. Sawai H, Okazaki T, Yamamoto H, et al. Requirement of AP-1 for ceramide-induced apoptosis in human leukemia HL-60 cells. J Biol Chem 1995; 270: 27326-31.
32. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270: 1326-31.
33. Zanke BW, Boudreau K, Rubie E, et al. The stress-activated protein kinase pathway mediated cell death following injury induced by cis-platinum, UV irradiation or heat. Current Biology 1996; 6: 606-13.
34. Kyriakis JM, Banerjee P, Nikolakaki E, et al. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 1994; 369: 156-60.
35. Dérijard B, Hibi M, Wu I-H, et al. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 1994; 76: 1025-37.
36. Sánchez I, Hughes RT, Mayer BJ, et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 1994; 372: 794-8.
37. Yan M, Dai T, Deak JC, et al. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 1994; 372: 798-800.
38. Lin A, Minden A, Martinetto H, et al. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 1995; 268: 286-90.
39. Westwick JK, Bielawska AE, Dbaibo G, Hannun YA, Brenner DA. Ceramide activates the stress-activated protein kinase. J Biol Chem 1995; 270: 22689-92.
40. Dérijard B, Raingeaud J, Barrett T, et al. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 1995; 267: 682-5.
41. Brown PH, Chen TK, Birrer MJ. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 1993; 9: 791-9.
42. Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature 1991; 353: 670-4.
43. Smeal T, Binetruy B, Mercola D, et al. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 1992; 12: 3507-13.
44. Dewey WC, Ling CC, Meyn RE. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 1995; 33: 781-96.
45. Cuvillier O, Pirianov G, Kleuser B, et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381: 800-3.
46. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 268: 14553-6.
47. Haimovitz-Friedman A, Balaban N, McLoughlin M, et al. Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-induced apoptosis. Cancer Res 1994; 54: 2591-7.
48. Fuks Z, Persaud RS, Alfieri A, et al. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res 1994; 54: 2582-90.
49. Unger C, Sindermann H, Peukert M, Hilgard P, Engel J, Eibl H. Hexadecylphosphocholine in the topical treatment of skin metastases in breast cancer patients. Progress in Experimental Tumor Research. Basel: Karger, 1992: 153-9.
50. Dummer R, Roger J, Vogt T, et al. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Progress in Experimental Tumor Research. Basel: Karger, 1992: 160-9.
51. Wieder T, Geilen CC, Reutter W. Antagonism of phorbol-ester-stimulated phosphatidylcholine biosynthesis by the phospholipid analogue hexadecylphosphocholine. Biochem J 1993; 291: 561-7.
52. Boggs KP, Rock CO, Jackowski S. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-O-methyl-rac-glycero-3-phosphocholine. J Biol Chem 1995; 270: 11612-8.
53. Maly K, Uberall F, Schubert C, et al. Interference of new alkylphospholipid analogues with mitogenic signal transduction. Anti-Cancer Drug Design 1995; 10: 411-25.
54. Mollinedo F, Gajate C, Modolell M. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem J 1994; 302: 325-9.
55. L. Cancer Res 1997; 57: 1320-8.
56. Mollinedo F, Martinez-Dalman R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Biochem Biophys Res Commun 1993; 192: 603-9.
57. Diomede L, Piovani B, Re F, et al. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int J Cancer 1994; 57: 645-9.
58. Hendry JH, Potten CS. Intestinal cell radiosensitivity: a comparison for cell death assayed by apoptosis or by a loss of clonogenicity. Int J Radiat Biol 1982; 42: 621-8.
59. Stephens LC, King GK, Peters LJ, Ang KK, Schultheiss TE, Jardine JH. Acute and late radiation injury in rhesus monkey parotic glands. Am J Pathol 1986; 124: 469-78.
60. Stephens LC, Schultheiss TE, Small SS, Ang KK, Peters LJ. Response of parotid gland organ culture to radiation. Radiat Res 1989; 120: 140-53.
61. Stephens LC, Ang KK, Schultheiss TE, Milas L, Meyn RE. Apoptosis in irradiated murine tumors. Radiat Res 1991; 127: 308-16.
62. Meyn RE, Stephens LC, Ang KK, Hunter N, Milas L, Peters LJ. Heterogeneity in apoptosis development in irradiated murine tumors. Int J Radiat Biol 1993; 64: 583-91.
63. Meyn RE, Stephens LC, Hendry JH. Workshop report: Radiation-induced apoptosis, 5-8 May 1994, Round Top, Texas, USA. Int J Radiat Biol 1994; 66: 655-9.
64. Wheeler JA, Stephens LC, Tornos C, et al. ASTRO research fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. Int J Radiat Oncol Biol Phys 1995; 32: 1487-93.
65. Levine EL, Renehan A, Gossiel R, et al. Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol 1995; 37: 1-9.
66. Leoncini L, Del Vecchio MT, Megha T, et al. Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 1993; 142: 755-63.
67. Vesalainen S, Lipponen P, Talja M, Syrjänen K. Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. Eur J Cancer 1994; 12: 1797-803.
68. Aihara M, Scardino PT, Truong LD, et al. The frequency of apoptosis correlates with the prognosis of Gleason grade 3 adenocarcinoma of the prostate. Cancer 1995; 2: 522-9.
69. Törmänen U, Eerola A-K, Rainio P, et al. Enhanced apoptosis predicts shortened survival in non-small cell lung caner. Cancer Res 1995; 55: 5595-602.
70. Chyle V, Pollack L, Czerniak B, et al. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int J Radit Oncol Biol Phys 1996; 2: 281-7.
71. Czader M, Mazur J, Pettersson M. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphoma. Cancer 1996; 6: 1180-8.
72. Komaki R, Fujii T, Perkins P, et al. Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1996; 3: 601-5.
73. Logsdon MD, McDonald TJ, Pugh WC, et al. Apoptosis, Bcl-2, and BAX as predictors of tumor response in stage I and II follicular lymphoma. 44th Annual Meeting of the Radiation Research Society 1996; abstract P19-326: 156.
74. Dubray B, Breton C, Delic J, et al. In vitro radiation-induced apoptosis and early response to low-dose radiotherapy in non-Hodgkin's lymphomas. Radiother Oncol 1998; 46: 185-91.